This research addresses the use of computational techniques for the modelling, simulation and prediction of complex biological systems.
The research presented an original methodology dealing specifically with the analysis of microarray and survival data in order to build prognostic models and provide an honest estimation of their performance. The approach used for signature extraction consists of a set of original methods for feature transformation, feature selection and prediction model building. A novel statistical framework was presented for performance assessment and comparison of risk prediction models. Such interdisciplinary contributions have brought new insights in biological processes critical to a patient’s clinical outcome and have been published both in top bioinformatics journals such as Bioinformatics, Genome Biol, PNAS, and BMC Genomics, and clinical journals such as Nature Medicine, Lancet Oncology, J Natl Cancer Inst , J Clin Oncology, Clin Cancer Res and Breast Cancer Research.
2. Inference of complex networks for expression data (in collaboration with Bordet Hospital, Erasme and CSAIL MIT) :
We developed computationally efficient and theoretically founded techniques for inferring large networks of dependencies from expression measures. We proposed a set of information theoretic approaches which rely on the estimation of mutual information and conditional mutual information from data in order to measure the statistical dependence between genes expression. These techniques have been published in bioinformatics journals such as BMC Bioinformatics, EURASIP and were adopted in the context of the Drosophila Model Organism Encyclopedia Of DNA Elements project (modENCODE) consortium then leading to a Science publication where P.E. Meyer appears as co-first author. Also, packages for feature selection and network inference have been made available in the R/Bioconductor framework
and are gradually considered to be ageneral property for every protein inside the cell. In simple terms the developed method is able to identify how information flows through the structures of the proteins. The insights obtained from this work have both theoretical and medical impact. Currently, the computational predictions are being validated using NMR relaxation experiments, biophysical analysis and in vivo experimentation.
like Imatinib and Nilotinib, providing in this way insight into clinical data [4-6]. One recent important contribution showed that stochastic effects at the level of the stem cell pool and early progenitors leads to the loss of the original cancer cell that drives the disease [4]. This result has raised the interest of clinicians since implies that TKI might be capable of curing a patient, which is up to now still considered to be impossible.Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer